860628 | C24 Dihydroceramide (d18:0/24:0)
N-lignoceroyl-D-erythro-sphinganine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C24 Dihydroceramide (d18:0/24:0)
N-lignoceroyl-D-erythro-sphinganine
CAS Registry Number is a Registered Trademark of the American Chemical Society
C24 Sphinganine
C24 dihydrosphingosine
N-(tetracosanoyl)-sphinganine
Yao H, Gong J, Peterson AL, Lu X, Zhang P, Dennery PA. Fatty Acid Oxidation Protects Against Hyperoxia-Induced Endothelial Cell Apoptosis and Lung Injury in Neonatal Mice. Am J Respir Cell Mol Biol. 2018 Dec 20. doi: 10.1165/rcmb.2018-0335OC. [Epub ahead of print]
PubMed ID: 30571144Effects of 6-Hydroxyceramides on the Thermotropic Phase Behavior and Permeability of Model Skin Lipid Membranes Andrej Kováčik†, Michaela Šilarová†, Petra Pullmannová†, Jaroslav Maixner‡, and Kateřina Vávrová*† Langmuir, Article ASAP
PubMed ID: 28230380Kováčik A, Pullmannová P, Maixner J, Vávrová K Effects of Ceramide and Dihydroceramide Stereochemistry at C-3 on the Phase Behavior and Permeability of Skin Lipid Membranes. Langmuir. 2017 Dec 26. doi: 10.1021/acs.langmuir.7b03448
PubMed ID: 29228775Kováčik A, Šilarová M, Pullmannová P, Maixner J, Vávrová K. Effects of 6-Hydroxyceramides on the Thermotropic Phase Behavior and Permeability of Model Skin Lipid Membranes. Langmuir. 2017 Mar 21;33(11):2890-2899. doi: 10.1021/acs.langmuir.7b00184. Epub 2017 Mar 6.
PubMed ID: 28230380- Certificate of Analysis (Lot No. 860628P-10MG-A-012 and 6056PIA012)
- Certificate of Analysis (Lot No. 860628P-25MG-A-012 and 6056PJA012)
- Certificate of Analysis (Lot No. 860628P-50MG-A-012 and 6056PKA012)
- Certificate of Analysis (Lot No. 860628P-5MG-A-012 and 6056PHA012)
- Certificate of Analysis (Lot No. 860628P-25MG-B-012 and 6056PJB012)
- Certificate of Analysis (Lot No. 860628P-5MG-B-012 and 6056PHB012)
- Certificate of Analysis (Lot No. 860628P-25MG-A-013 and 6056PJA013)
- Certificate of Analysis (Lot No. 860628P-5MG-A-013 and 6056PHA013)
- Certificate of Analysis (Lot No. 860628P-5MG-C-012 and 6056PHC012)
- Certificate of Analysis (Lot No. 860628P-5MG-B-011 and 6056PHB011)
- Certificate of Analysis (Lot No. 860628P-5MG-B-013 and 6056PHB013)
- Certificate of Analysis (Lot No. 860628P-5MG-E-013 and 6056PHE013)
- Certificate of Analysis (Lot No. 860628P-5MG-F-013 and 6056PHF013)
- Certificate of Analysis (Lot No. 860628P-25MG-B-013 and 6056PJB013)
- Certificate of Analysis (Lot No. 860628P-5MG-H-013 and 6056PHH013)
- Certificate of Analysis (Lot No. 860628P-5MG-I-013 and 6056PHI013)
- Certificate of Analysis (Lot No. 860628P-25MG-C-013 and 6056PJC013)